Cipher Pharmaceuticals Inc.
CPHRF
$12.00
-$0.56-4.46%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 141.97% | -6.65% | 124.58% | -21.53% | 1,081.63% |
| Total Depreciation and Amortization | 0.22% | -0.66% | -0.82% | 20.58% | -21.51% |
| Total Amortization of Deferred Charges | 15.38% | 5.41% | -2.63% | -2.56% | 77.27% |
| Total Other Non-Cash Items | -3,577.54% | 70.61% | -62.55% | 87.88% | -20,485.00% |
| Change in Net Operating Assets | -38.45% | 500.33% | -497.39% | -97.15% | 3,353.23% |
| Cash from Operations | -18.87% | 78.70% | 42.65% | -52.50% | 343.81% |
| Capital Expenditure | -2,400.00% | -- | 100.00% | 71.43% | 99.99% |
| Sale of Property, Plant, and Equipment | -100.00% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -16.25% | -- | -- | -- | -- |
| Cash from Investing | -340.82% | -- | 100.00% | 71.43% | 99.99% |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | 32.97% | 19.98% | -19,739.47% | -8.57% | 33.96% |
| Issuance of Common Stock | 186.67% | 350.00% | -67.74% | 106.67% | 50.00% |
| Repurchase of Common Stock | -4.94% | 26.27% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 87.69% |
| Cash from Financing | 29.29% | 20.98% | -38,146.67% | 56.73% | -100.26% |
| Foreign Exchange rate Adjustments | 161.48% | -123.02% | 5,400.00% | 97.83% | -986.54% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 68.06% | 72.66% | -356.09% | -49.92% | 121.61% |